BridgeMD
New treatment option for Advanced Malignant Solid Neoplasm
Official title Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
ClinicalTrials.gov ID: NCT07174661
What this study is testing
- What it's testing
- This clinical trial studies whether educational tools work to improve early advance care planning (ACP) in adolescents and young adults (AYAs) with solid tumors that may have spread from where they first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and high-grade brain tumors. The incidence of AYA cancers is on the rise with approximately 90,000 new diagnoses yearly in the United States.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 39
You may be able to join if
- Age 18-39 at initial cancer diagnosis
- Patient \<18 years of age are not included in this pilot as Mayo Clinic in Arizona (MCA) does not treat pediatric patients
- Recently diagnosed (defined as 12 months or less from initial diagnosis or advance stage relapse) with either a stage III/IV solid malignancy or...
- Actively receiving primary oncologic care at Mayo Clinic Arizona
- Able to read, understand, and speak English
You likely can't join if
- Age \ 39 at initial cancer diagnosis
- Diagnosed with stage I/II solid malignancy, low-grade brain tumor, or hematologic malignancy
- Not receiving primary oncologic care at Mayo Clinic Arizona
- Unable to read, understand, and speak English
- Patients \> 12 months from initial diagnosis or advanced stage relapses, in survivorship or on hospice
- No internet or computer/smart phone access
See the full eligibility criteria
- Age 18-39 at initial cancer diagnosis
- Patient \<18 years of age are not included in this pilot as Mayo Clinic in Arizona (MCA) does not treat pediatric patients
- Recently diagnosed (defined as 12 months or less from initial diagnosis or advance stage relapse) with either a stage III/IV solid malignancy or high-grade brain tumor. This includes patients who have stage III/IV...
- Actively receiving primary oncologic care at Mayo Clinic Arizona
- Able to read, understand, and speak English
- Those who have completed prior advanced directive documents are still eligible to participate.
- Age \ 39 at initial cancer diagnosis
- Diagnosed with stage I/II solid malignancy, low-grade brain tumor, or hematologic malignancy
- Not receiving primary oncologic care at Mayo Clinic Arizona
- Unable to read, understand, and speak English
- Patients \> 12 months from initial diagnosis or advanced stage relapses, in survivorship or on hospice
- No internet or computer/smart phone access
The study team makes the final eligibility decision.
Where it's taking place
- Scottsdale, Arizona, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 39 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Scottsdale, Arizona, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.